Fayez Sarofim & CO Regeneron Pharmaceuticals, Inc. Transaction History

Fayez Sarofim & CO

$38.7 Billion
Q3 2024

A detailed history of Fayez Sarofim & CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fayez Sarofim & CO holds 2,675 shares of REGN stock, worth $2.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,675

Previous 2,675 -0.0%

Holding current value

$2.02 Million

Previous $2.81 Million 0.04%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $66,799 - $73,507	-74 Reduced 2.69%	2,675 $2.57 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $57,363 - $65,245	74 Added 2.77%	2,749 $2.41 Million
Q1 2023 May 11, 2023	BUY	$680.49 - $826.97 $17,012 - $20,674	25 Added 0.94%	2,675 $2.2 Million
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $211,767 - $229,917	300 Added 12.77%	2,650 $1.91 Million
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $27,417 - $36,942	50 Added 2.17%	2,350 $1.39 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $297,560 - $349,215	500 Added 27.78%	2,300 $1.61 Million
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $706,524 - $872,261	1,300 Added 260.0%	1,800 $1.14 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $141,840 - $167,562	-300 Reduced 37.5%	500 $279,000
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $171,097 - $209,960	-383 Reduced 32.38%	800 $379,000
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $59,787 - $75,997	125 Added 11.81%	1,183 $572,000
Q1 2020 May 12, 2020	SELL	$336.18 - $494.43 $33,618 - $49,443	-100 Reduced 8.64%	1,058 $517,000
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $68,090 - $80,441	183 Added 18.77%	1,158 $475,000
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $50,373 - $60,456	150 Added 18.18%	975 $364,000
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $13,091 - $15,869	-46 Reduced 5.28%	825 $285,000
Q1 2018 May 10, 2018	SELL	$315.82 - $393.78 $12,001 - $14,963	-38 Reduced 4.18%	871 $300,000
Q4 2017 Feb 13, 2018	BUY	$358.63 - $469.95 $16,496 - $21,617	46 Added 5.33%	909 $342,000
Q3 2017 Nov 08, 2017	BUY	$431.38 - $504.0 $372,280 - $434,952	863	863 $386,000

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Account